Rezultati pretraživanja
  1. 2. velj

    closes its IPO of 2,300,000 shares of its common stock at $6.00 per share

  2. 30. sij

    Recent pharma happenings: sells stock amid bull market, raises USD 12 Million; Pharmaceuticals merges with Histogen, in an all-stock transaction; gives up on making a version of ;

  3. 28. sij

    Next we have is CFO, Jeffrey McGroarty. Annovis Bio is in the mist of a phase II trial on ALZ and hoping to begin one for Parkinson’s in the near future.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.